My Mindful Moments: A Mindfulness Meditation and Digital Art Activity

Mindfulness Clinical Trial

Official title:

My Mindful Moments: A Mindfulness Meditation and Digital Art Activity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04557033
• Other study ID #: 20-420
• Status: Completed
• Phase: N/A
• Start date: July 1, 2021
• Est. completion date: July 30, 2022

Study information

• Verified date: August 2022
• Source: Dana-Farber Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this evidence-based practice project is to evaluate the feasibility of providing a relaxation mindfulness meditation and an expressive digital arts activity among clinical staff at Dana Farber Cancer Institute .

Description:

This project provides an opportunity for patient care staff in an ambulatory oncology setting to participate in and evaluate an activity that includes a mindfulness meditation technique and an expressive digital arts activity. This study will be conducted to evaluate the feasibility of providing a mindfulness meditation and digital imagery activity. - The activity will include a guided mindfulness meditation and the creation of a digital image on an iPad. - Participants will be asked to complete brief surveys before and after the intervention activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: July 30, 2022
• Est. primary completion date: July 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults =18 years of age
• Currently employed at Dana Farber Cancer Institute
• Providing patient care on Yawkey

Exclusion Criteria:

• Not an employee of Dana Farber Cancer Institute
• Not providing Patient Care on Yawkey

Related Conditions & MeSH terms

• Meditation
• Mindfulness

Intervention

Other:
• Mindfulness intervention
My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media

Locations

Country	Name	City	State
United States	Dana Farber Cancer Institute	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Dana-Farber Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of Participation-Feasibility	=50% of staff choose to participate=Feasibility. This measure of feasibility will be evaluated by calculating index scores of the percentage of clinical staff who choose to participate	1 year
Primary	Percentage Completion of Full Activity-Feasibility	> 80% of those who participate complete the activity=Feasibility. This measure of feasibility will be evaluated by index scores of the percentage of clinical staff who complete the full activity	1 year
Primary	Mean Completion Time-Feasibility	The activity is completed by the group in 40 minutes or less-Feasibility. This measure of feasibility will be evaluatedby individual group completions times and overall analysis of descriptive statistics on the time for completion of the activity by all groups.	1 year
Secondary	Change in Anxiety Score	Changes in participant state anxiety will be evaluated using the visual analogue scale in measuring state anxiety. The electronic scale displays a horizontal line divided into 30 equal-sized partitions. The left edge of the scale is marked "calm" and the right edge is marked "anxious." A sliding locator is positioned at the midpoint of the scale. The participant is instructed to use the computer mouse to place the locator at the scale position representing their current level of anxiety. The score is automatically calculated by rounding the relative distance of the locator from the left edge of the scale to the nearest integer value between 0 and 30. A higher score indicates greater anxiety. A comparison of scores pre- and post- intervention by calculating a paired t-test comparison of means	1 Year